The Validity and Reliability Study of the Turkish Adaptation of Medical Adherence Report Scale

Şen, Esin Temeloğlu; Berk, Özlem Sertel; Sindel, Dilşad

doi:10.26650/iuitfd.413637

Cited by 23 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The current study used the Turkish version of MARS, which was previously validated to measure treatment adherence for all chronic diseases requiring long-term medication. The internal consistency coefficient (.78) and overall item correlations (ranging from .35 to .71) in this study were similar to those in the original version [20]. The internal consistency coefficient (Cronbach α) was also calculated using the baseline data.…”

Section: Assessment Of Medication Adherencesupporting

confidence: 65%

Assessment of physical function, quality of life, and medication adherence in elderly patients with rheumatic diseases

Sultanoğlu

Ataoğlu

Avşar

et al. 2021

Egypt Rheumatol Rehabil

View full text Add to dashboard Cite

Background The proportion of older people in the total population has increased in Turkey as well as worldwide. As life expectancy rises, the increasing prevalence of rheumatic diseases poses major problems in the elderly. Comorbid diseases and the aging-induced changes in the endogenous immune response and the pharmacokinetic properties of therapeutic agents may complicate the decision to use a particular drug and result in a different clinical picture and treatment response. We, therefore, aimed to investigate the characteristics of chronic inflammatory diseases, their impact on physical function and quality of life, the prevalence of comorbid diseases that may complicate treatment planning, and treatment adherence in patients aged 65 years or older. Results One hundred seventy-four patients were included and divided into two age groups: 18–64 years (group 1, n = 85) and 65 years or older (group 2, n = 89). The mean age of all recruited patients was 57.55 ± 16.98 years. Of 174, 99 (56.9%) were female and 75 (43.1%) were male. The mean duration of rheumatic disease was 7 ± 4.8 years and age at onset was 51.46 ± 14.78 years. Gender distribution differed significantly by age group (P = 0.024). The percentage of females in group 1 was 48.2% and 65.2% in group 2. The occupational status also differed significantly by age group (P < 0.001). 48.2% of group 1 were employed and 57.3% of group 2 were housewives. Marital status varied significantly by age (P < 0.001). The percentage of married was 74.1% in group 1 and the percentage of separated/divorced/widowed in group 2 was 28.1%. There was no difference between groups 1 and 2 in terms of place of residence (P = 0.459). The prevalence of comorbid diseases and the rate of use of medications for comorbid diseases (non-rheumatic treatments) were higher in elderly patients. The rate of use of disease-modifying anti-rheumatic drugs (DMARDs) was 30.3% and biological agents 61.8% in the elderly group (≥ 65 years) (group 2) (P < 0.001). There were positive correlations between, Health Assessment Questionnaire (HAQ), Bath Ankylosing Spondylitis Functional Index (BASFI) and Nottingham Health Profile (NHP) domains in both groups. There was also a significant negative correlation between Medication Adherence Rating Scale (MARS) and all dimensions. Conclusions Elderly and younger patients with rheumatic diseases have different demographic and clinical characteristics. Physical function and quality of life are more affected by rheumatic diseases and treatment adherence is poorer in the elderly. Our study found a positive correlation between physical function and quality of life in both age groups. The treatment adherence rating scale showed a negative correlation with physical function and quality of life scores, with individuals with poor treatment adherence having worse physical function and quality of life.

show abstract

Section: Assessment Of Medication Adherencesupporting

confidence: 65%

Assessment of physical function, quality of life, and medication adherence in elderly patients with rheumatic diseases

Sultanoğlu

Ataoğlu

Avşar

et al. 2021

Egypt Rheumatol Rehabil

View full text Add to dashboard Cite

show abstract

Self‐reported medication adherence in differentiated thyroid cancer survivors: Role of illness perception and medication beliefs

2020

View full text Add to dashboard Cite

Background: To investigate medication adherence (MA) to Levothyroxine in differentiated thyroid cancer survivors and analyze the related factors for nonadherence. Methods: The Medication Adherence Report Scale (MARS), Hospital Anxiety and Depression Scale (HAD), Brief Illness Perception Questionnaire (B-IPQ), and Beliefs about Medicines Questionnaire (BMQ) were used to assess MA. Results: Nonadherence was reported in 77 of 197 patients (39.1%). Socioeconomic status and education levels were found to be significantly related to MA. The HAD scores, all items of B-IPQ, and BMQ were associated with MA and showed a correlation with the MARS scores. The primary predictors of MA were greater confidence in treatment modality (odds ratio [OR]: 0.48, 95% confidence interval (CI): 0.37-0.63) and greater belief that the medication had minimal risk of harm (OR: 3.35, 95% CI: 1.50-7.49). Conclusions: Special attention should be paid to educational programs for differentiated thyroid carcinoma patients concerning the effectiveness and low risk of harm of medication in order to improve MA.

show abstract

Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases

Samuelyan,

Ay,

Moon

et al. 2024

Eur J Clin Pharmacol

View full text Add to dashboard Cite

The Validity and Reliability Study of the Turkish Adaptation of Medical Adherence Report Scale

Cited by 23 publications

References 21 publications

Assessment of physical function, quality of life, and medication adherence in elderly patients with rheumatic diseases

Assessment of physical function, quality of life, and medication adherence in elderly patients with rheumatic diseases

Self‐reported medication adherence in differentiated thyroid cancer survivors: Role of illness perception and medication beliefs

Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases

Contact Info

Product

Resources

About